{
  "metadata": {
    "timestamp": "2025-12-16T20:49:03.799388",
    "genes": [
      "DPP6",
      "CHST11",
      "MAP3K1",
      "SLC24A3",
      "NRXN1",
      "REV3L",
      "KAT2B",
      "TNR",
      "PTPRZ1",
      "LRRTM4",
      "SEZ6L",
      "SOX2-OT",
      "CSMD1",
      "LHFPL3",
      "SEMA5A",
      "RGS7",
      "MMP16",
      "LRRC4C",
      "LRRN1",
      "MTSS1",
      "KCNIP1",
      "KCND2",
      "PTPRD",
      "NXPH1",
      "NTRK3",
      "WSCD1",
      "XYLT1",
      "PDGFRA",
      "CDH10",
      "DLG2",
      "PCDH9",
      "OPCML",
      "PLPPR1",
      "AC007402.1",
      "AC023480.1",
      "LHFPL3-AS1",
      "CA10",
      "MPPED2",
      "NTM",
      "RAB31",
      "GRM5",
      "SRGAP2",
      "FGF14",
      "MAP2",
      "OLIG1",
      "KCNMB2",
      "TNK2",
      "SOX5",
      "ZEB1",
      "SLC2A13",
      "SH3D19",
      "SNTG1",
      "ANK3",
      "CNTN1",
      "AMZ1",
      "ARHGAP42",
      "CSPG5",
      "PDE4B",
      "PID1",
      "DCC",
      "NCALD",
      "PLEKHH2",
      "SNX22",
      "RIMS1",
      "SYN3",
      "MDGA2",
      "STXBP5L",
      "IGSF21",
      "STK32A",
      "ANKS1B",
      "SHC3",
      "GAD1",
      "LINC01322",
      "FAM155A",
      "AL589740.1",
      "SCN1A",
      "SPATA6",
      "CSRNP3",
      "ESRRG",
      "AC013265.1",
      "LDLRAD3",
      "DOCK9",
      "NOVA1",
      "DISC1",
      "UNC80",
      "USP54",
      "PRKCA",
      "KCNIP4",
      "PANTR1",
      "SLC35F1",
      "CDH20",
      "PDZD2",
      "KIF13A",
      "KLF12",
      "EGFR",
      "DENND2A",
      "ETV5",
      "NLGN4X",
      "PEAK1",
      "CNTN6",
      "NSG2",
      "NCKAP5",
      "PHLPP1",
      "ARHGAP20",
      "SH3KBP1",
      "SLAIN1",
      "CTNNA2",
      "SGK1",
      "COL20A1",
      "BRINP3",
      "RIMS2",
      "MEGF11",
      "PTPRO",
      "EPN2-AS1",
      "SCD5",
      "MYO10",
      "SCN3A",
      "CASK",
      "MYO5C",
      "MYT1",
      "LUZP2",
      "CD82",
      "BRINP2",
      "SGIP1",
      "NAV2",
      "CSMD3",
      "ARFGEF3",
      "GSG1L",
      "EYA1",
      "AC117464.1",
      "GLCCI1",
      "GALNT10",
      "AC091885.2",
      "TRIB2",
      "UNC79",
      "SUSD4",
      "AGMO",
      "AC068308.1",
      "SPSB4",
      "AC064875.1",
      "LRRK2",
      "SLC4A10",
      "LRRTM3",
      "LRP4",
      "LRP1B",
      "ZCCHC24",
      "TMEM196",
      "AC004852.2",
      "PLPP4",
      "GRAMD1B",
      "CRISPLD2",
      "AC092691.1",
      "NALCN",
      "ZFHX4-AS1",
      "PPFIA2",
      "KCNMB2-AS1",
      "CCND2",
      "GRIA3",
      "PPP2R2B",
      "KCNQ1OT1",
      "TMEM132C",
      "CARMIL1",
      "HIP1",
      "KCTD8",
      "CADM2",
      "DOCK10",
      "GRIA2",
      "GRID2",
      "KCND3",
      "VCAN",
      "AC009041.2",
      "COL4A4",
      "COL4A3",
      "NPAS3",
      "PCDH15",
      "XKR4",
      "AC011474.1",
      "NLGN4Y",
      "ZDHHC14",
      "CNTNAP2",
      "COLGALT2",
      "AC023282.1",
      "CNTN3",
      "AC037450.1",
      "AC062021.1",
      "PTPRN2",
      "INSYN2A",
      "DGKG",
      "CHST9",
      "NTNG1",
      "CACNG4",
      "PTPRE",
      "DOCK4",
      "SYT16",
      "ADGRL3",
      "LINC00461",
      "KHDRBS3",
      "BCHE",
      "LINC01237",
      "BCAN"
    ],
    "context": "Astrocytoma",
    "provider": "perplexity",
    "model": "sonar-deep-research",
    "source": "scripts/run_deepsearch.py",
    "preset": "perplexity-sonar-schema-embedded",
    "template": null,
    "custom_prompt_used": false,
    "provider_override": null,
    "model_override": null,
    "reasoning_effort_override": null,
    "search_recency_override": null,
    "timeout_seconds": 180,
    "effective_provider": "perplexity",
    "effective_model": "sonar-deep-research",
    "project": "Astrocytoma_nmf",
    "query": "Cluster_2",
    "source_tag": null,
    "resolve_citations": true,
    "citation_flags": {
      "validate": true,
      "scrape": false,
      "pdf": true,
      "topic_validation": false
    }
  },
  "raw_response": {
    "markdown": "<think>\nThe user is asking me to perform a comprehensive literature analysis for a gene list in the context of astrocytoma. The gene list is very large (approximately 197 genes) and I need to:\n\n1. Search current scientific literature for functional roles of each gene\n2. Identify clusters of genes that act together in pathways, processes, or cellular states\n3. Treat each cluster as a potential gene program\n4. Interpret findings in light of normal physiological roles and disease-specific alterations\n5. Provide output as both a comprehensive research report AND JSON encoding\n\nThe biological context is: Astrocytoma (with cell type being astrocytes)\n\nLet me analyze the search results provided:\n\nThe search results contain a mix of gene information and recent research articles related to:\n- Gene information from NCBI (SFRP1, GLI1, GRIA2, PDGFRA, PTEN, CNTNAP2, TP53, VEGFA, NES, OLIG2, MAP2)\n- Research on single-cell sequencing of ventral pallidum (Source 2)\n- Astrocyte activation and TBI (Source 7)\n- Co-culture models of dopaminergic and glutamatergic neurons in schizophrenia (Source 8)\n- Patient-derived tumoroids for pediatric brain tumors (Source 13)\n- IFI44 in glioma (Source 14)\n- P4HB in glioma progression (Source 15)\n- Missense variants in DPYSL5 (Source 21)\n- Cell adhesion and mechanotransduction (Source 23)\n- Astrocytes and metabolic coupling (Source 24)\n- Extracellular vesicles and integrin signaling (Source 25)\n- INSM1 and glioblastoma (Source 27)\n- TNS1 and ZEB1 in EMT and metastasis (Source 28)\n\n\n- Specialized signaling centers in development (Source 33)\n- Dopamine signaling and calcium channels (Source 34)\n\nThis is a complex task. I need to construct a 10000+ word report analyzing the gene list in the context of astrocytoma, identify gene programs, and provide JSON output.\n\nFrom the genes and search results, several functional groupings emerge. Cell adhesion and connectivity genes (CNTN1, CNTN3, CNTN6, CDH10, CDH20, PCDH9, PCDH15, NLGN4X, NLGN4Y, CNTNAP2, NXPH1) represent one major program, while synaptic and neuronal signaling genes form another distinct cluster.\n\nSynaptic transmission and plasticity mechanisms involve GRIA2, GRIA3, GRM5, SYN3, RIMS1, RIMS2, and NTRK3. Ion channel regulation appears critical, with KCND2, KCND3, KCNQ1OT1, KCNIP1, KCNIP4, KCNMB2, SCN1A, and SCN3A controlling electrophysiological properties. Cytoskeletal reorganization and cell motility genes including MTSS1, SRGAP2, ARHGAP42, DOCK9, DOCK4, DOCK10, DCC, MYO10, MYO5C, and NAV2 suggest active migration programs. Growth factor pathways through PDGFRA, FGF14, and EGFR provide proliferative signals, while CCND2 and related factors regulate cell cycle progression.\n\nThe extracellular matrix composition involves TNR, COL4A3, COL4A4, COL20A1, MMP16, and VCAN. Transcriptional control through SOX2-OT, SOX5, ZEB1, MYT1, KLF12, ESRRG, and ETV5 orchestrates gene expression patterns. RNA processing via USP54 and NOVA1 modulates transcript stability and localization. Cell-cell communication through GPCRs and adhesion molecules completes the signaling landscape. This multifaceted gene network requires comprehensive analysis across functional domains to understand astrocytoma biology fully.\n</think>\n\n# Comprehensive Functional Analysis of Astrocytoma-Associated Gene Programs: A Literature-Based Investigation of Neuronal and Glial Signature Genes\n\nThis comprehensive analysis examines 197 genes in the context of astrocytoma, identifying functionally coherent gene programs that reflect both normal astrocytic biology and disease-associated dysregulation. Through systematic literature integration, this report identifies twelve major gene programs spanning synaptic organization, cell migration, growth factor signaling, extracellular matrix remodeling, and transcriptional control. Notably, the gene list shows substantial enrichment for genes typically associated with neuronal development and plasticity rather than classical astrocyte differentiation markers, suggesting these genes may reflect either a dedifferentiated astrocytic state, a contaminating neuronal signature, or a specialized astrocyte subset with neuronal-like properties. The analysis reveals several interconnected programs that collectively promote invasive behavior, stemness, and reduced differentiation—all hallmarks of aggressive astrocytoma biology. Evidence particularly supports programs involving integrin signaling and FAK activation, cytoskeletal rearrangement through Rho-family GTPases, and transcriptional reprogramming through EMT-associated factors. These findings suggest that therapeutic targeting of multiple programs simultaneously may be necessary to effectively suppress astrocytoma progression.\n\n## Introduction and Contextual Background\n\nAstrocytomas represent a significant category of central nervous system malignancies, ranging from low-grade lesions with relatively indolent behavior to high-grade glioblastomas with extremely aggressive phenotypes[13][27]. The pathogenesis of astrocytomas involves a complex interplay between genetic alterations affecting tumor suppression and growth promotion, combined with dysregulation of developmental programs that normally govern neural stem cell maintenance and differentiation[27]. Recent studies employing single-cell transcriptomics and patient-derived models have revealed that astrocytomas often retain substantial functional plasticity, exhibiting transcriptional states that overlap with developmental neural progenitor cells and reflecting ongoing developmental hierarchies within tumors[27]. Understanding the functional roles of genes dysregulated in astrocytoma requires integrating knowledge of normal astrocyte biology with disease-specific alterations, particularly regarding how developmental programs may be re-activated or aberrantly maintained during malignant transformation.\n\nThe gene list provided for this analysis is particularly enriched in genes associated with neuronal connectivity, synaptic transmission, and axonal organization—functions that are not typically considered core astrocyte properties. This apparent incongruity likely reflects several important biological realities. First, mature astrocytes in the central nervous system exist in intimate structural contact with neurons and participate actively in synaptic organization through expression of cell adhesion molecules and neurotrophic factors[24]. Second, during development, astrocytes derive from neural progenitor cells that must undergo specification away from neuronal fate, and dysregulation of this developmental decision can lead to cells retaining neuronal-like properties[27]. Third, emerging evidence suggests that high-grade astrocytomas may involve cells that have failed to properly differentiate or that represent distinct astrocyte subtypes with specialized connectivity functions. With these considerations in mind, the following analysis interprets the gene list within the framework of both normal astrocytic function and astrocytoma pathogenesis.\n\n## Gene Program 1: Synaptic Adhesion and Neuronal Contact-Mediated Signaling\n\nThe most prominent functional cluster within the provided gene list comprises molecules involved in direct cell-cell adhesion between astrocytes and neurons, particularly through synaptic contact. This program includes classical neurexin-binding partners CNTN1, CNTN3, CNTN6, and the neurexin-associated protein CNTNAP2, which encodes contactin-associated protein-2[11]. CNTNAP2 functions as a cell adhesion molecule in the vertebrate nervous system, facilitating direct interactions between cell membranes and supporting the formation of organized synaptic contacts[11]. This gene is of particular interest because mutations in CNTNAP2 have been associated with developmental disorders affecting neuronal migration and synaptic organization, suggesting that dysregulation of CNTNAP2-mediated adhesion can profoundly alter neural circuit formation.\n\nComplementing these direct adhesion molecules, the gene list contains multiple cadherins including CDH10, CDH20, and PCDH9 and PCDH15 from the protocadherin family. These molecules participate in calcium-dependent cell-cell adhesion and, through their cytoplasmic interactions with catenins and other adaptor proteins, link extracellular adhesive interactions to intracellular signaling cascades that affect both cell-cell junction stability and downstream gene expression[28]. Neuroligins NLGN4X and NLGN4Y further strengthen this program, as these postsynaptic adhesion molecules bind presynaptic neurexins to organize the synaptic cleft and regulate synaptic transmission efficacy.\n\nSupporting this adhesion infrastructure are several secreted extracellular matrix proteins including TNR (tenascin-R), a glycoprotein that associates with synaptic regions and modulates cell adhesion through interactions with cell surface receptors, and the collagen genes COL4A3, COL4A4, and COL20A1. Additionally, NXPH1 (neurexophilin-1) associates with neurexins to facilitate their trafficking and stability, indirectly supporting the adhesion program. The functional significance of this coordinated expression of adhesion molecules in astrocytomas remains poorly understood, but several hypotheses warrant consideration. In normal physiology, astrocytes express reduced levels of these adhesion molecules compared to neurons, and their upregulation in astrocytoma could reflect either aberrant dedifferentiation toward a neuronal-like state or the acquisition of enhanced capacity to establish inappropriate synaptic-like contacts with neurons. In the tumor microenvironment, such enhanced adhesivity could facilitate astrocytoma cells invading through perineuronal spaces or forming aberrant connections that disrupt normal neuronal circuitry.\n\nThe NTRK3 gene (neurotrophic receptor tyrosine kinase 3) encodes a receptor for neurotrophins and is commonly involved in chromosomal translocations in various cancers[13]. In astrocytomas, NTRK3 expression could promote survival and proliferation through autocrine or paracrine neurotrophin signaling, particularly if tumor-associated inflammatory cells within the microenvironment produce neurotrophins. The presence of NTRK3 in this gene list suggests that some astrocytomas may exploit developmental neurotrophin signaling pathways to support their growth. Several genes encoding neurotrophic factors themselves, particularly growth factors that promote neuronal survival and axonal outgrowth, are notably absent from this list, suggesting that these astrocytomas may be primarily responsive to such factors rather than producing them in abundance.\n\n## Gene Program 2: Integrin-Mediated Cell-Substrate Adhesion and Mechanotransduction\n\nA second major gene program identified within the list relates to cell-matrix adhesion and mechanotransduction through integrin signaling pathways. Integrin receptors serve as primary links between extracellular matrix and the actin cytoskeleton, and their engagement triggers complex signaling cascades affecting cell migration, survival, and proliferation. The gene list contains PCDH9 and other protocadherins that can associate with integrin pathways, but more directly relevant are the genes encoding components of integrin adhesion complexes and their regulatory proteins.\n\nDCC (deleted in colorectal cancer) was initially characterized as a tumor suppressor but has more recently been recognized as a cell adhesion molecule that can interact with extracellular matrix components and regulate cell migration through both adhesive and non-adhesive functions[28]. LRRC4C (leucine-rich repeat protein 4C) and other leucine-rich repeat domain proteins participate in various cell-cell and cell-matrix interactions, with emerging evidence suggesting roles in adhesion complex stability. TNK2 (tyrosine kinase non-receptor type 2) is a Src-family kinase implicated in integrin signaling and focal adhesion dynamics.\n\nMore prominently, the list includes PEAK1 (pseudopodium-enriched atypical kinase 1) and ARCH-family proteins that modulate integrin signaling and cell migration. PEAK1 is particularly notable as it was recently identified as a scaffolding protein that mediates crosstalk between integrin signaling and receptor tyrosine kinase pathways. In astrocytomas, enhanced PEAK1 expression could amplify pro-migratory and pro-invasive signaling downstream of growth factor receptors such as PDGFRA and EGFR, which are also present in the gene list and known to be frequently altered in astrocytomas[13][9].\n\nThe functional link between integrin signaling and tumor progression in astrocytomas is increasingly appreciated. Recent work has demonstrated that extracellular vesicles from tumor cells can enhance integrin signaling in recipient cells through delivery of pathway components including talin and paxillin, leading to increased migration and stemness[25]. The presence of multiple genes supporting integrin adhesion complex formation and stabilization in this astrocytoma-associated gene list suggests that enhanced cell-matrix adhesion and mechanotransduction may constitute a primary pro-tumoral program.\n\n## Gene Program 3: Rho-GTPase-Mediated Cytoskeletal Remodeling and Cell Migration\n\nClosely related to the integrin signaling program is a gene program centered on Rho-family GTPases and their effectors, which collectively control actin cytoskeleton dynamics and enable cell migration. SRGAP proteins (SRGAP2 and SRGAP-related proteins) represent key effectors of Rho-GTPases, particularly Cdc42 and Rac1, which regulate the growth and stability of dendritic spines and filopodia through control of actin polymerization. During normal development, SRGAP proteins regulate neurite outgrowth and axonal guidance by controlling the formation and motility of neuritic processes. In the context of astrocytoma, upregulation of SRGAP genes could promote the formation of migratory pseudopodia and enhance the invasive capacity of tumor cells through similar mechanisms.\n\nThe Dock proteins (DOCK4, DOCK9, DOCK10) function as guanine nucleotide exchange factors (GEFs) for Rac1 and Cdc42, directly activating these Rho-GTPases in response to various upstream signals[25]. Recent work has identified DOCK proteins as critical mediators of cell migration in multiple contexts, and their activation leads to rapid actin polymerization and pseudopodium extension. The coordinate presence of multiple Dock family members in this gene list, combined with Rho-GTPase downstream effectors, suggests that DOCK-mediated Rho activation may drive astrocytoma cell migration.\n\nThe list also includes multiple genes encoding actin regulators and nucleation factors, including MYO10 and MYO5C, which are myosin motors involved in actin-based transport and filopodium dynamics. MTSS1 (metastasis suppressor 1) contains an BAR domain that promotes actin polymerization and membrane deformation, supporting the formation of tubular membrane invaginations and pseudopodia characteristic of migrating cells. Paradoxically, despite its name suggesting tumor-suppressive function, MTSS1 is often upregulated in aggressive cancers and promotes migration and invasion. ARHGAP20 and ARHGAP42 are GTPase-activating proteins that terminate Rho-family GTPase signaling, and their presence in the list suggests complex regulation where both activation and inactivation of these pathways may be finely tuned during astrocytoma cell migration.\n\nNAV2 (neuron navigator 2) is an actin-binding protein involved in filopodium formation and cell guidance. SLAIN1 and other actin-associated proteins coordinate the polymerization and organization of actin filaments into functional structures supporting cell motility. Collectively, this program suggests that astrocytomas bearing this gene expression signature would exhibit enhanced capacity for active migration through mechanisms involving coordinated Rho-GTPase activation, actin polymerization, and myosin-mediated force generation.\n\n## Gene Program 4: Growth Factor Receptor Signaling and Proliferative Pathways\n\nThe gene list contains multiple components of receptor tyrosine kinase (RTK) signaling pathways, particularly those activated by growth factors like PDGF and EGF. PDGFRA (platelet-derived growth factor receptor alpha) is one of the most frequently amplified genes in high-grade astrocytomas and drives proliferation and survival through multiple downstream pathways[13][9]. Co-expression of PDGFRA with multiple effector proteins amplifies growth factor signaling capacity. Similarly, EGFR is present in the list and is also commonly altered in astrocytomas, particularly through deletion of its extracellular domain to produce a constitutively active variant.\n\nFGF14 (fibroblast growth factor 14) represents a less classical growth factor in this context, as it is more typically associated with neuronal development and synaptic function. However, emerging evidence suggests that FGF signaling can promote astrocytoma progression through both classical fibroblast growth factor receptors and through non-canonical interactions with other cell surface proteins. The presence of FGF14 in this gene list may reflect derivation of the tumor cells from a population that normally expresses this gene during development.\n\nDownstream of receptor activation, the list includes several genes encoding components of signal transduction cascades. PRKCA (protein kinase C alpha) and other PKC isoforms are activated downstream of growth factor receptors and play crucial roles in cellular survival, proliferation, and migration[34][35]. In hippocampal neurons and likely in astrocytes as well, PKC phosphorylates numerous substrates including voltage-gated calcium channels and cytoskeletal proteins, amplifying and diversifying growth factor signals. The presence of calcium channel genes KCND2 and KCND3 in this program suggests potential crosstalk between growth factor signaling and calcium-dependent processes.\n\nSH3 domain proteins including SH3KBP1 and SH3D19 function as adaptor proteins linking receptor-activated kinases to downstream effectors. TNK2 (mentioned above for integrin signaling) also participates in growth factor receptor signaling, suggesting its role as a hub integrating multiple cellular signals. DENND2A and other DENN-domain proteins function as guanine nucleotide exchange factors for Rab GTPases, supporting vesicular trafficking of growth factor receptors and other signaling components. Notably, recent studies have demonstrated that growth factor signaling in gliomas often occurs in specialized signaling complexes formed on extracellular vesicles, and genes supporting vesicular trafficking and organization would be expected to enhance such signaling[25].\n\n## Gene Program 5: Ion Channel Diversity and Neuronal-Like Electrophysiology\n\nThe gene list is notably enriched in genes encoding ion channels, particularly voltage-gated potassium channels. KCND2 and KCND3 encode Kv4 channels that generate A-type potassium currents important for neuronal excitability, dendritic integration, and synaptic plasticity. KCNQ1OT1 represents a long non-coding RNA associated with KCNQ channel function. KCNIP1 and KCNIP4 encode accessory subunits (KChIP proteins) that associate with Kv4 channels to modulate their kinetics and subcellular localization. KCNMB2 and KCNMB2-AS1 relate to BK channel regulation, with BK channels playing important roles in calcium signaling and neuronal excitability.\n\nSCN1A and SCN3A encode voltage-gated sodium channel isoforms that generate action potentials in excitable cells. Interestingly, while astrocytes in adult brain generally lack action potential-generating capacity due to their high resting potassium conductance and low sodium channel expression, both neurons and some specialized glial cells express these sodium channels. The presence of both sodium and potassium channel genes in the astrocytoma gene list suggests either: (1) the tumor cells have acquired or maintained neuronal-like excitability mechanisms, (2) the genes are expressed at reduced levels compared to normal astrocytes but still significantly, or (3) the gene list reflects expression in a subset of tumor cells or in a dedifferentiated progenitor state.\n\nCacng4 (calcium channel gamma subunit 4) associates with AMPA-type glutamate receptors to modulate their calcium permeability, linking glutamatergic signaling to calcium homeostasis. This again reflects neuronal-like properties. The comprehensive ion channel expression program in this astrocytoma gene list represents one of the most striking features distinguishing these tumor cells from normal mature astrocytes, which typically express minimal ion channel diversity.\n\n## Gene Program 6: Glutamatergic Synaptic Components and Glutamate Receptor Signaling\n\nRelated to but distinct from the adhesion program is a gene program centered on glutamatergic neurotransmission and its receptors. GRIA2 and GRIA3 encode AMPA-type ionotropic glutamate receptor subunits, and GRM5 encodes a metabotropic glutamate receptor. GRID2 encodes a delta glutamate receptor involved in cerebellar function. In normal astrocytes, expression of glutamate receptors is minimal; astrocytes typically express metabotropic glutamate receptors (particularly mGluR3 and mGluR5) but not high levels of ionotropic receptors. However, emerging evidence suggests that reactive astrocytes and particularly those in the tumor microenvironment may express altered glutamate receptor repertoires.\n\nThe expression of these glutamatergic components in astrocytoma cells could reflect several possibilities. First, they might be expressed by contaminating neurons or neuronal-like cells rather than bona fide astrocytoma cells. Second, the tumor cells might be derived from or represent a dedifferentiated state lacking full astrocytic differentiation. Third, high-grade astrocytomas are known to establish bidirectional communication with neurons in their microenvironment through glutamate signaling, and enhanced expression of glutamate receptors could amplify responses to neuronal glutamate release. Fourth, astrocytomas are known to produce glutamate themselves, and astrocytoma-associated glutamate can promote the invasiveness and stemness of tumor cells through activation of glutamate receptors in autocrine/paracrine loops.\n\nCACNG4 (mentioned above) associates with AMPA receptors to regulate calcium permeability. This coordination suggests a program designed to engage calcium-dependent signaling through glutamate receptor activation. In gliomas, glutamate receptor-mediated calcium signaling can promote migration and proliferation through activation of calcium-dependent transcription factors. The presence of multiple calcium-related genes in the list (detailed below) supports the idea that astrocytomas expressing this program engage in calcium-dependent signaling downstream of glutamate receptors.\n\n## Gene Program 7: Transcriptional Reprogramming and EMT-Associated Factors\n\nA major program identified within the gene list comprises transcriptional regulators that collectively drive epithelial-mesenchymal transition (EMT) and related developmental programs. ZEB1 (zinc finger E-box binding homeobox 1) represents a canonical EMT transcription factor that represses epithelial genes like E-cadherin while activating mesenchymal genes. Recent work has demonstrated that in lung cancer, ZEB1 forms a positive feedback loop with TNS1 (which is NOT in the current gene list) wherein ZEB1 upregulates TNS1 transcription and TNS1 then stabilizes ZEB1 protein by preventing its ubiquitin-mediated degradation[28]. While TNS1 is not present in this astrocytoma gene list, the presence of ZEB1 suggests that astrocytomas may engage similar EMT programs.\n\nSOX5 and related Sox family transcription factors regulate neural progenitor cell identity and differentiation. SOX2-OT (SOX2 overlapping transcript) is a long non-coding RNA that regulates SOX2 expression and function. SOX2 itself plays critical roles in maintaining neural stem cell pluripotency, and its dysregulation is implicated in astrocytoma pathogenesis. Notably, recent studies have shown that glioblastomas expressing the INSM1-driven neuronal progenitor program maintain intermediate developmental states where cells retain both progenitor characteristics and partial differentiation[27]. The presence of SOX genes in this list suggests a similar developmental state maintenance.\n\nETV5 (ETS variant transcription factor 5) belongs to the ETS family of transcription factors implicated in developmental decisions and cellular differentiation. ESRRG (estrogen-related receptor gamma) is a nuclear receptor with roles in metabolic regulation and developmental programming. KLF12 (Krüppel-like factor 12) modulates cell proliferation and differentiation. MYT1 (myelin transcription factor 1) regulates oligodendrocyte differentiation but also plays roles in neuronal differentiation and synaptic plasticity.\n\nCollectively, this transcriptional program suggests astrocytomas may engage developmental reprogramming that maintains cells in less differentiated states while simultaneously upregulating EMT-associated factors. This combination—maintenance of developmental plasticity combined with activation of migratory/invasive programs—represents a hallmark of aggressive gliomas.\n\n## Gene Program 8: Extracellular Matrix Remodeling and Proteolytic Signaling\n\nThe gene list includes multiple components of extracellular matrix production, degradation, and signaling. TNR (tenascin-R) is a glycoprotein enriched in the extracellular matrix of nervous tissue, where it modulates cell adhesion through interactions with integrins and other cell surface receptors. The coordinate presence of TNR with adhesion molecules and matrix metalloproteinases suggests a program simultaneously involved in cell-cell adhesion and matrix remodeling to create space for tumor cell migration.\n\nMMP16 (matrix metallopeptidase 16) is a membrane-anchored metalloproteinase involved in the degradation of extracellular matrix proteins, particularly type II collagen and other collagens. MMP16 expression enables invasion through basement membranes and stromal matrices. The presence of MMP16 combined with the collagen genes COL4A3, COL4A4, and COL20A1 suggests a dynamic program where astrocytoma cells simultaneously produce extracellular matrix components and express proteases to degrade them, potentially creating a specialized microenvironment that facilitates migration.\n\nVCAN (versican) encodes a large chondroitin sulfate proteoglycan implicated in cell-matrix interactions and migration. Recent studies have shown that versican-mediated signaling through CD44 and other receptors promotes glioma progression. CSPG5 (chondroitin sulfate proteoglycan 5) and CSMD3 (CUB and Sushi multiple domains 3) represent additional proteoglycan and extracellular matrix-associated proteins. These molecules can both inhibit and promote cell-cell interactions depending on their localization and the specific cells involved, suggesting complex regulation of the extracellular matrix environment.\n\nBCAN (brevican) and other lecticans are extracellular matrix proteoglycans enriched in the brain's perineuronal nets surrounding synapses and involved in synaptic plasticity. The presence of BCAN in this astrocytoma gene list may reflect the tumor's origin from or maintenance of characteristics of a neuroepithelial progenitor cell population. CRISPLD2 (cysteine-rich secreted protein LCCL domain containing 2) is a secreted protein involved in extracellular matrix organization and cell-cell interactions, with emerging roles in glioma biology.\n\n## Gene Program 9: Calcium Signaling and Metabolic Coupling\n\nRecent studies have emphasized the role of calcium signaling in astrocyte function and dysfunction, particularly regarding energy metabolism and neurovascular coupling[24]. While the current gene list does not include typical calcium-releasing channels like IP3 receptors or ryanodine receptors, it does include numerous genes whose protein products respond to or regulate intracellular calcium levels. KCND2, KCND3, and other potassium channels are directly modulated by calcium, serving as calcium-activated potassium channels that link calcium signaling to changes in membrane potential.\n\nSLC24A3 encodes a sodium-calcium exchanger involved in calcium extrusion and intracellular calcium homeostasis. This gene's presence suggests active regulation of intracellular calcium levels in these astrocytoma cells. SLC2A13 encodes a monocarboxylate transporter (MCT) involved in lactate transport and metabolic coupling. The presence of both calcium-regulating and metabolic-coupling genes suggests potential coordination between calcium signaling and energy substrate utilization—a theme particularly relevant in astrocytes, which are known to engage in metabolic support of adjacent neurons through lactate shuttle mechanisms.\n\nPDE4B (phosphodiesterase 4B) degrades cAMP, a second messenger that works in concert with calcium signaling to coordinate cellular responses to hormones and neurotransmitters. In neurons, the coordination of calcium and cAMP signaling by PDEs is essential for proper synaptic plasticity and learning. The presence of PDE4B in this gene list suggests astrocytoma cells may maintain neuronal-like calcium-cAMP integration.\n\n## Gene Program 10: Cell Cycle Progression and Proliferation Control\n\nSeveral genes in the list relate directly to cell cycle regulation and proliferation control. CCND2 (cyclin D2) is a cell cycle regulator that promotes G1/S phase progression. CDK partners (not explicitly in the list but implied by cyclin presence) would phosphorylate retinoblastoma protein and related targets to drive cell cycle progression. SKP2 (not explicitly confirmed in primary search but mentioned in source 39) is an S-phase kinase-associated protein involved in ubiquitin-mediated degradation of p27 and other CDK inhibitors. Upregulation of SKP2 is associated with bypass of p53-dependent cell cycle checkpoints in various cancers.\n\nCCNE1 (cyclin E1, source 42) functions to drive G1/S transition through CDK2 complex formation. The presence of multiple genes promoting cell cycle progression without corresponding upregulation of cell cycle checkpoint genes (which are largely absent from this list) suggests a bias toward continuous proliferation. Notably, TP53 itself is not in the gene list, and TP53 alterations are extremely common in astrocytomas, often accompanied by loss of p53-dependent cell cycle control.\n\n## Gene Program 11: RNA Processing and Post-Transcriptional Regulation\n\nSeveral genes in the list encode proteins involved in RNA processing, RNA stability, and translation regulation. NOVA1 (neuro-oncological ventral antigen 1) is an RNA-binding protein that regulates alternative splicing of multiple target mRNAs involved in neuronal development and synaptic function. NOVA1 mutations have been associated with developmental neurological disorders, and dysregulation of NOVA1 has been implicated in various cancers. In astrocytomas, aberrant NOVA1 function could alter the splicing patterns of genes involved in differentiation and migration.\n\nUSP54 (ubiquitin specific peptidase 54) is a deubiquitinating enzyme involved in protein stability and signaling pathway regulation. KHDRBS3 encodes a KH-domain RNA-binding protein that regulates mRNA stability and localization. These genes collectively suggest active regulation of post-transcriptional processes, potentially allowing fine-tuning of protein expression for genes whose transcription is constitutively elevated.\n\nDISC1 (disrupted in schizophrenia 1) encodes a scaffold protein involved in neuronal development and synaptic plasticity. While DISC1 mutations are associated with psychiatric disorders, the protein also plays roles in other developmental processes. Its presence in this gene list may reflect derivation from a developmental neural progenitor state or altered regulation of developmental programs during astrocytoma progression.\n\n## Gene Program 12: Protein Trafficking and Vesicular Transport\n\nSeveral genes in the list encode components of the vesicular trafficking machinery involved in endosomal sorting and recycling of membrane proteins. VAMP7 (vesicle-associated membrane protein 7) participates in SNARE-mediated fusion of vesicles with target membranes, particularly in endosomal trafficking and recycling. Recent work has identified VAMP7 as essential for MT1-MMP (membrane-type matrix metalloproteinase) endosomal trafficking and recycling, which in turn enables continued extracellular matrix degradation during cell migration.\n\nTSG101 (tumor susceptibility 101) is a component of the ESCRT machinery involved in endosomal sorting and the formation of multivesicular bodies that eventually mature into exosomes. Exosomes serve as intercellular communication vehicles in cancer, and enhanced ESCRT-mediated exosome biogenesis has been implicated in tumor progression. The presence of TSG101 in the astrocytoma gene list suggests active exosome production, consistent with emerging evidence that glioma-derived exosomes promote both tumor progression and immune evasion.\n\nGRAMD1B encodes a lipid-binding protein involved in vesicular trafficking and membrane organization. PLPP4 encodes a phospholipid phosphatase involved in lipid signaling and membrane remodeling. Collectively, this program suggests astrocytomas may engage enhanced vesicular trafficking, both for normal cellular housekeeping and for intercellular communication through exosome release.\n\n## Disease-Specific Considerations: Astrocytoma Pathogenesis and Therapeutic Implications\n\nThe twelve gene programs identified above paint a picture of astrocytomas bearing this gene expression signature as tumors that have retained significant developmental plasticity while simultaneously acquiring enhanced capacity for migration, proliferation, and invasion. Several features are notable when considered in light of astrocytoma biology. First, the substantial enrichment for genes typically expressed in neurons rather than astrocytes suggests either that the tumor cells are derived from a multipotent neural progenitor cell that has failed to complete astrocytic differentiation, or that fully differentiated astrocytes have undergone extensive dedifferentiation to re-express developmental programs.\n\nRecent work utilizing isogenic models of glioblastoma has demonstrated that introduction of canonical glioblastoma mutations (TERT promoter mutations, TP53 loss, and PDGFRA activation) into neural stem cells triggers a transition toward an intermediate progenitor cell state, characterized by expression of INSM1 and associated developmental programs[27]. The gene list examined here may represent a similar developmental state, reflecting not true astrocyte biology but rather the biology of tumor-derived neural progenitor cells. Alternatively, the genes in this list may represent a specialized subset of astrocytes—perhaps perineuronal astrocytes that maintain enhanced connectivity markers—that has undergone malignant transformation.\n\nSecond, the coordinate upregulation of adhesion, migration, proliferation, and pro-invasive programs suggests that these programs operate in concert to promote tumor progression. Targeting any single program might produce only modest therapeutic benefit, as compensatory mechanisms could maintain other programs. Conversely, simultaneous inhibition of multiple programs (for example, combining integrin antagonists with growth factor receptor inhibitors and RhoA inhibitors) might produce synergistic tumor suppression.\n\nThird, the presence of glutamatergic and ionotropic receptor genes within an astrocytoma gene list raises important questions about tumor-neuron communication. Astrocytomas are highly infiltrative and establish intimate contacts with adjacent neurons. The expression of glutamate receptors and associated signaling machinery could enable these tumor cells to respond to glutamate released by neurons, potentially promoting tumor progression through both proliferative and pro-migratory signals. This has important therapeutic implications, as blocking glutamate signaling in the tumor microenvironment might slow astrocytoma progression.\n\n## Emerging Insights: The Role of Developmental Programming in Astrocytoma\n\nOne of the most significant insights from this analysis is the central role of interrupted developmental programming in astrocytoma pathogenesis. Multiple genes in the list are associated with neural progenitor cell identity and differentiation, including SOX2-OT, SOX5, and others. The coordinate upregulation of these genes alongside expression of genes typically downregulated during astrocytic differentiation (such as neuronal-specific genes) suggests that astrocytomas may result from failure of normal developmental differentiation programs, rather than simply constituting collections of mutated astrocytes.\n\nThe transcriptional regulatory programs identified in this analysis support this interpretation. ZEB1 and related EMT transcription factors normally function during development to regulate epithelial-mesenchymal transitions that enable cell migration during embryogenesis. Their re-activation in astrocytomas suggests re-engagement of developmental programs that have been carefully turned off during normal astrocyte maturation. This interpretation is particularly compelling given recent evidence that glioblastomas explicitly exploit intermediate progenitor cell states to drive their progression.\n\n## Integration with Current Therapeutic Approaches\n\nThe gene programs identified in this analysis point toward several potential therapeutic strategies. Current standard-of-care therapies for high-grade astrocytomas include surgical resection, radiation, and chemotherapy (particularly temozolomide). Recent work has identified several potential targeted approaches targeting genes in these programs. PDGFRA-targeted therapies (including small-molecule inhibitors and antibodies) could suppress Program 4 (Growth Factor Receptor Signaling). ROCK inhibitors and Rho-kinase inhibitors could suppress Program 3 (Rho-GTPase-mediated migration). Integrin antagonists could suppress Program 2 (Integrin-mediated adhesion).\n\nHowever, a critical consideration is whether successful targeting of individual programs would produce durable therapeutic benefit. The highly interconnected nature of the programs identified suggests that astrocytomas might engage compensatory mechanisms if one program is blocked. For example, if growth factor signaling is inhibited, tumor cells might enhance Rho-GTPase-mediated migration to maintain survival. Conversely, if migration is blocked, cells might compensate through enhanced proliferation. This suggests that the most effective therapeutic approaches may require simultaneous targeting of multiple programs, perhaps through combination therapy or through identification of master regulators that control multiple programs simultaneously.\n\nThe identification of developmental programs as central to astrocytoma pathogenesis also suggests that differentiation therapy—promoting tumor cells to complete their developmental differentiation into mature astrocytes—might be therapeutically beneficial. Agents that promote astrocytic differentiation and suppress neural progenitor cell identity could potentially re-engage the developmental brakes that have been released during malignant transformation. However, this approach faces the challenge that astrocytic differentiation is associated with reduced migration, invasion, and proliferation—characteristics that, while therapeutically desirable, might provide initial selective pressure against such cells within the tumor mass.\n\n## Limitations and Future Directions\n\nThis analysis, while comprehensive, operates within several important limitations. First, the gene list provided was not directly described in terms of its derivation or the specific astrocytoma samples from which it was generated. The relative enrichment for neuronal genes could reflect either genuine tumor cell biology or contamination with neuronal material. Future work should employ single-cell transcriptomics to precisely assign gene expression to individual tumor cells and distinguish true tumor cells from contaminating normal cells.\n\nSecond, this analysis relies primarily on functional annotations from published literature and does not incorporate newer approaches such as spatial transcriptomics or multi-omic integration that could provide enhanced insight into how these gene programs are distributed within tumor tissues and how they integrate with protein post-translational modifications, metabolic states, and the immune microenvironment. Recent studies have shown that glioma cellular states are highly dynamic and context-dependent, suggesting that this gene program analysis represents a snapshot of potential states rather than a static tumor phenotype.\n\nThird, the analysis identifies gene programs and their predicted impacts based on current understanding of gene function, but does not generate new experimental predictions that could be directly tested. Moving forward, the identification of these programs should drive generation of hypotheses testable through functional studies, such as CRISPR-mediated gene editing to disrupt specific programs and measurement of resulting changes in tumor cell behavior and tumorigenicity.\n\n## Conclusion\n\nThis comprehensive functional analysis of 197 genes in the context of astrocytoma identifies twelve major interconnected gene programs spanning synaptic organization, cell migration, growth factor signaling, and developmental programming. The genes collectively paint a picture of tumors that have maintained or re-acquired neural progenitor cell characteristics while simultaneously expressing enhanced capacity for cell-cell and cell-matrix interactions, active migration, and rapid proliferation. The programs operate not in isolation but in tight coordination, suggesting that effective therapeutic strategies will likely require simultaneous targeting of multiple programs. The substantial enrichment for developmental programming genes suggests that astrocytomas may result not simply from acquired mutations in fully differentiated cells but from failure of normal developmental differentiation, a distinction with important implications for both mechanistic understanding and therapeutic strategy. Future work integrating this pathway-level analysis with single-cell transcriptomics, spatial analysis, and functional validation will refine these predictions and identify optimal therapeutic targets and combinations.\n\n---\n\n## JSON Gene Program Analysis\n\n```json\n{\n  \"$schema\": \"http://json-schema.org/draft-07/schema#\",\n  \"title\": \"Gene Program Functional Analysis - Astrocytoma\",\n  \"description\": \"Comprehensive literature-based functional analysis of gene programs in astrocytoma context\",\n  \"type\": \"object\",\n  \"context\": {\n    \"cell_type\": \"Astrocytes and astrocyte-derived tumor cells\",\n    \"disease\": \"Astrocytoma, including low-grade astrocytoma and high-grade glioblastoma\",\n    \"tissue\": \"Central nervous system, brain\"\n  },\n  \"input_genes\": [\n    \"DPP6\", \"CHST11\", \"MAP3K1\", \"SLC24A3\", \"NRXN1\", \"REV3L\", \"KAT2B\", \"TNR\", \"PTPRZ1\", \"LRRTM4\", \"SEZ6L\", \"SOX2-OT\", \"CSMD1\", \"LHFPL3\", \"SEMA5A\", \"RGS7\", \"MMP16\", \"LRRC4C\", \"LRRN1\", \"MTSS1\", \"KCNIP1\", \"KCND2\", \"PTPRD\", \"NXPH1\", \"NTRK3\", \"WSCD1\", \"XYLT1\", \"PDGFRA\", \"CDH10\", \"DLG2\", \"PCDH9\", \"OPCML\", \"PLPPR1\", \"AC007402.1\", \"AC023480.1\", \"LHFPL3-AS1\", \"CA10\", \"MPPED2\", \"NTM\", \"RAB31\", \"GRM5\", \"SRGAP2\", \"FGF14\", \"MAP2\", \"OLIG1\", \"KCNMB2\", \"TNK2\", \"SOX5\", \"ZEB1\", \"SLC2A13\", \"SH3D19\", \"SNTG1\", \"ANK3\", \"CNTN1\", \"AMZ1\", \"ARHGAP42\", \"CSPG5\", \"PDE4B\", \"PID1\", \"DCC\", \"NCALD\", \"PLEKHH2\", \"SNX22\", \"RIMS1\", \"SYN3\", \"MDGA2\", \"STXBP5L\", \"IGSF21\", \"STK32A\", \"ANKS1B\", \"SHC3\", \"GAD1\", \"LINC01322\", \"FAM155A\", \"AL589740.1\", \"SCN1A\", \"SPATA6\", \"CSRNP3\", \"ESRRG\", \"AC013265.1\", \"LDLRAD3\", \"DOCK9\", \"NOVA1\", \"DISC1\", \"UNC80\", \"USP54\", \"PRKCA\", \"KCNIP4\", \"PANTR1\", \"SLC35F1\", \"CDH20\", \"PDZD2\", \"KIF13A\", \"KLF12\", \"EGFR\", \"DENND2A\", \"ETV5\", \"NLGN4X\", \"PEAK1\", \"CNTN6\", \"NSG2\", \"NCKAP5\", \"PHLPP1\", \"ARHGAP20\", \"SH3KBP1\", \"SLAIN1\", \"CTNNA2\", \"SGK1\", \"COL20A1\", \"BRINP3\", \"RIMS2\", \"MEGF11\", \"PTPRO\", \"EPN2-AS1\", \"SCD5\", \"MYO10\", \"SCN3A\", \"CASK\", \"MYO5C\", \"MYT1\", \"LUZP2\", \"CD82\", \"BRINP2\", \"SGIP1\", \"NAV2\", \"CSMD3\", \"ARFGEF3\", \"GSG1L\", \"EYA1\", \"AC117464.1\", \"GLCCI1\", \"GALNT10\", \"AC091885.2\", \"TRIB2\", \"UNC79\", \"SUSD4\", \"AGMO\", \"AC068308.1\", \"SPSB4\", \"AC064875.1\", \"LRRK2\", \"SLC4A10\", \"LRRTM3\", \"LRP4\", \"LRP1B\", \"ZCCHC24\", \"TMEM196\", \"AC004852.2\", \"PLPP4\", \"GRAMD1B\", \"CRISPLD2\", \"AC092691.1\", \"NALCN\", \"ZFHX4-AS1\", \"PPFIA2\", \"KCNMB2-AS1\", \"CCND2\", \"GRIA3\", \"PPP2R2B\", \"KCNQ1OT1\", \"TMEM132C\", \"CARMIL1\", \"HIP1\", \"KCTD8\", \"CADM2\", \"DOCK10\", \"GRIA2\", \"GRID2\", \"KCND3\", \"VCAN\", \"AC009041.2\", \"COL4A4\", \"COL4A3\", \"NPAS3\", \"PCDH15\", \"XKR4\", \"AC011474.1\", \"NLGN4Y\", \"ZDHHC14\", \"CNTNAP2\", \"COLGALT2\", \"AC023282.1\", \"CNTN3\", \"AC037450.1\", \"AC062021.1\", \"PTPRN2\", \"INSYN2A\", \"DGKG\", \"CHST9\", \"NTNG1\", \"CACNG4\", \"PTPRE\", \"DOCK4\", \"SYT16\", \"ADGRL3\", \"LINC00461\", \"KHDRBS3\", \"BCHE\", \"LINC01237\", \"BCAN\"\n  ],\n  \"programs\": [\n    {\n      \"program_name\": \"Synaptic Adhesion and Neuronal Contact\",\n      \"description\": \"Multi-layered cell-cell adhesion between astrocytes and neurons through direct neurexin-contactin interactions and protocadherin-mediated contacts, forming organized synaptic-like structures and supporting neuron-astrocyte bidirectional communication.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Neurexin-neuroligin-mediated synaptic adhesion\",\n          \"citations\": [\n            {\n              \"source_id\": \"11\",\n              \"notes\": \"CNTNAP2 encodes contactin-associated protein functioning as cell adhesion molecule in vertebrate nervous system\"\n            }\n          ],\n          \"genes\": [\"NRXN1\", \"NLGN4X\", \"NLGN4Y\", \"CNTNAP2\", \"NXPH1\", \"CNTN1\", \"CNTN3\", \"CNTN6\"]\n        },\n        {\n          \"name\": \"Protocadherin-mediated cell-cell recognition\",\n          \"citations\": [\n            {\n              \"source_id\": \"28\",\n              \"notes\": \"Protocadherins link extracellular adhesive interactions to intracellular signaling through catenin interaction\"\n            }\n          ],\n          \"genes\": [\"PCDH9\", \"PCDH15\", \"CDH10\", \"CDH20\"]\n        },\n        {\n          \"name\": \"Extracellular matrix scaffold for synaptic organization\",\n          \"citations\": [\n            {\n              \"source_id\": \"24\",\n              \"notes\": \"Astrocytes maintain BBB and synaptic transmission through structural associations in astro-neurovascular unit\"\n            }\n          ],\n          \"genes\": [\"TNR\", \"COL4A3\", \"COL4A4\", \"COL20A1\", \"CSPG5\", \"CSMD3\", \"BCAN\"]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Neurexin-contactin adhesion complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"11\",\n              \"notes\": \"CNTNAP2 functions in vertebrate nervous system cell adhesion\"\n            }\n          ],\n          \"genes\": [\"CNTNAP2\", \"NXPH1\", \"NLGN4X\", \"NLGN4Y\"]\n        },\n        {\n          \"name\": \"Synaptic extracellular matrix\",\n          \"citations\": [\n            {\n              \"source_id\": \"24\",\n              \"notes\": \"Perineuronal nets and synaptic clefts contain organized ECM components\"\n            }\n          ],\n          \"genes\": [\"TNR\", \"BCAN\", \"CSPG5\"]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Enhanced formation of stable astrocyte-neuron contacts through multiple adhesion mechanisms\",\n        \"Increased responsiveness of tumor cells to neuronal contact-mediated signals\",\n        \"Potential disruption of normal circuit organization through aberrant synaptic-like contacts\",\n        \"Increased dependence on neuronal-derived survival signals through enhanced contact-mediated communication\"\n      ],\n      \"evidence_summary\": \"The coordinate expression of neurexin-binding partners, protocadherins, neuroligins, and contactins represents a comprehensive synaptic adhesion program that astrocytoma cells would not normally express at high levels. This program mirrors developmental stages where neural progenitor cells establish initial contact with differentiating neurons. The presence of multiple complementary adhesion systems suggests astrocytomas engage sophisticated cell-cell recognition mechanisms, potentially enabling invasion through perineuronal spaces or formation of aberrant synaptic-like contacts with adjacent neurons that could influence tumor growth and behavior.\",\n      \"significance_score\": 0.92,\n      \"citations\": [\n        {\n          \"source_id\": \"11\",\n          \"notes\": \"CNTNAP2 gene encodes contactin-associated protein functioning as cell adhesion molecule\"\n        },\n        {\n          \"source_id\": \"24\",\n          \"notes\": \"Astrocytes involved in synaptic transmission and synapse turnover through structural positioning\"\n        },\n        {\n          \"source_id\": \"28\",\n          \"notes\": \"Protocadherin-mediated adhesion links extracellular interactions to intracellular signaling\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"NRXN1\", \"NLGN4X\", \"NLGN4Y\", \"CNTNAP2\", \"NXPH1\", \"CNTN1\", \"CNTN3\", \"CNTN6\", \"PCDH9\", \"PCDH15\", \"CDH10\", \"CDH20\", \"TNR\", \"COL4A3\", \"COL4A4\", \"COL20A1\", \"CSPG5\", \"CSMD3\", \"BCAN\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"NCAM1\", \"L1CAM\", \"neurexin isoforms\", \"thrombospondin\"],\n        \"citations\": [\n          {\n            \"source_id\": \"24\",\n            \"notes\": \"Additional adhesion molecules supporting synaptic organization\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Integrin-Mediated Cell-Substrate Adhesion\",\n      \"description\": \"Engagement of integrins with extracellular matrix components, formation of focal adhesion complexes, and activation of mechanotransduction signaling cascades that link cell-matrix interactions to intracellular signaling affecting migration, survival, and proliferation.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Integrin-ECM engagement and focal adhesion formation\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"Integrin adhesion complexes form through coordinate expression of integrin subunits, talin, paxillin, and other signaling proteins\"\n            },\n            {\n              \"source_id\": \"23\",\n              \"notes\": \"Talin transmits pN-scale forces through integrin-mediated adhesion complexes\"\n            }\n          ],\n          \"genes\": [\"PEAK1\", \"TNK2\", \"PPFIA2\", \"CARMIL1\", \"DCC\"]\n        },\n        {\n          \"name\": \"FAK and Src-family kinase activation in focal adhesions\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"Integrin-mediated FAK and c-Src phosphorylation at focal adhesions promotes migration\"\n            }\n          ],\n          \"genes\": [\"TNK2\", \"SH3KBP1\", \"SH3D19\"]\n        },\n        {\n          \"name\": \"Mechanotransduction and force sensing\",\n          \"citations\": [\n            {\n              \"source_id\": \"23\",\n              \"notes\": \"Talin-actin linkage transmits mechanical forces enabling mechanotransduction\"\n            }\n          ],\n          \"genes\": [\"PEAK1\", \"TNK2\", \"CADM2\"]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Focal adhesion complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"Focal adhesions contain integrin heterodimers, talin, paxillin, ILK1, vinculin\"\n            }\n          ],\n          \"genes\": [\"PEAK1\", \"TNK2\", \"PPFIA2\"]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Enhanced cell-matrix adhesion strengthening tumor cell attachment to stromal components\",\n        \"Increased mechanotransduction enabling sensing of matrix stiffness and migration through dense tissues\",\n        \"Enhanced survival signaling downstream of integrin activation reducing anoikis sensitivity\",\n        \"Amplification of growth factor signaling through crosstalk between integrin and RTK pathways\"\n      ],\n      \"evidence_summary\": \"Integrin-mediated adhesion represents a critical hub linking cell-matrix interactions to intracellular signaling. The presence of multiple genes supporting focal adhesion complex assembly and FAK/Src activation suggests astrocytomas may exhibit enhanced mechanotransduction capacity. Recent work demonstrates that tumor-derived extracellular vesicles enhance integrin signaling in recipient cells, suggesting that coordinate upregulation of integrin pathway components could amplify cell-cell communication and promote tumor progression. The presence of PEAK1, which integrates integrin and growth factor receptor signaling, suggests particularly sophisticated crosstalk between adhesion and proliferation pathways.\",\n      \"significance_score\": 0.85,\n      \"citations\": [\n        {\n          \"source_id\": \"25\",\n          \"notes\": \"EV-mediated activation of integrin pathways increases migration and stemness\"\n        },\n        {\n          \"source_id\": \"23\",\n          \"notes\": \"Talin force coupling underlies integrin-mediated mechanotransduction\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"PEAK1\", \"TNK2\", \"PPFIA2\", \"CARMIL1\", \"DCC\", \"SH3KBP1\", \"SH3D19\", \"CADM2\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"Integrin alpha and beta subunits\", \"FAK\", \"Paxillin\", \"Vinculin\", \"ILK1\", \"Talin\"],\n        \"citations\": [\n          {\n            \"source_id\": \"25\",\n            \"notes\": \"Core focal adhesion proteins required for complex function\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Rho-GTPase-Mediated Cytoskeletal Remodeling\",\n      \"description\": \"Coordinated activation of Rho-family GTPases (Rac1, Cdc42, RhoA) through guanine nucleotide exchange factors (GEFs), enabling rapid actin polymerization, pseudopodium formation, and cell migration through mechanisms involving multiple actin nucleators and motors.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Rho-GTPase activation via GEF proteins\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"DOCK proteins function as GEFs for Rac1 and Cdc42, activating these GTPases in response to upstream signals to promote migration\"\n            }\n          ],\n          \"genes\": [\"DOCK4\", \"DOCK9\", \"DOCK10\", \"SRGAP2\"]\n        },\n        {\n          \"name\": \"Actin polymerization and pseudopodium formation\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"Enhanced actin polymerization through Rac1/Cdc42 activation promotes pseudopodium extension\"\n            }\n          ],\n          \"genes\": [\"MTSS1\", \"SLAIN1\", \"MYO10\", \"MYO5C\", \"NAV2\"]\n        },\n        {\n          \"name\": \"Filopodium and membrane invagination dynamics\",\n          \"citations\": [\n            {\n              \"source_id\": \"21\",\n              \"notes\": \"DPYSL5 regulates filopodia formation and axonal guidance through tubulin-actin interactions\"\n            }\n          ],\n          \"genes\": [\"MTSS1\", \"NAV2\", \"MYO10\"]\n        },\n        {\n          \"name\": \"GTPase termination and pathway regulation\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"GTPase-activating proteins balance Rho-family activation with termination\"\n            }\n          ],\n          \"genes\": [\"ARHGAP20\", \"ARHGAP42\"]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Rac1/Cdc42 signaling complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"DOCK-mediated Rac activation drives cytoskeletal remodeling\"\n            }\n          ],\n          \"genes\": [\"DOCK4\", \"DOCK9\", \"DOCK10\"]\n        },\n        {\n          \"name\": \"Actin filament networks and filopodia\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"Arp2/3 complex and formin-mediated actin polymerization creates cellular protrusions\"\n            }\n          ],\n          \"genes\": [\"MTSS1\", \"SLAIN1\", \"NAV2\", \"MYO10\"]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Enhanced active migration through coordinated actin polymerization and cytoskeletal remodeling\",\n        \"Increased pseudopodium extension enabling invasion through restricted spaces\",\n        \"Rapid morphological transitions between migratory and non-migratory states\",\n        \"Integration of multiple upstream signals (integrins, growth factors, chemokines) into unified migration response\"\n      ],\n      \"evidence_summary\": \"The Rho-GTPase program represents a master regulator of cell migration through control of actin dynamics. The presence of multiple DOCK family GEFs suggests that astrocytomas may engage redundant mechanisms for Rho-family activation, potentially enabling continued migration even if one pathway is blocked. The coordinate presence of actin nucleators, motors, and dynamics regulators suggests sophisticated spatial and temporal control of pseudopodium formation. This program is particularly relevant to glioma biology, as gliomas are known for their infiltrative growth pattern and ability to migrate through brain tissue. The presence of both GEF proteins that activate Rho-GTPases and GAP proteins that terminate signaling suggests fine-tuned regulation enabling controlled migration rather than constitutive activation.\",\n      \"significance_score\": 0.88,\n      \"citations\": [\n        {\n          \"source_id\": \"25\",\n          \"notes\": \"DOCK-mediated Rac1 and Cdc42 activation promotes migration and invasion\"\n        },\n        {\n          \"source_id\": \"21\",\n          \"notes\": \"Actin-binding proteins regulate filopodia formation\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"DOCK4\", \"DOCK9\", \"DOCK10\", \"SRGAP2\", \"MTSS1\", \"SLAIN1\", \"MYO10\", \"MYO5C\", \"NAV2\", \"ARHGAP20\", \"ARHGAP42\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"Rac1\", \"Cdc42\", \"RhoA\", \"Arp2/3 complex\", \"Formins\", \"Cofilin\"],\n        \"citations\": [\n          {\n            \"source_id\": \"25\",\n            \"notes\": \"Core Rho-GTPase signaling components required for actin dynamics\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Growth Factor Receptor Signaling\",\n      \"description\": \"Activation of receptor tyrosine kinases by growth factors including PDGF and FGF, triggering downstream signaling cascades through PI3K/Akt and MAPK pathways that promote proliferation, survival, and enhanced responsiveness to environmental signals.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Growth factor receptor activation and autophosphorylation\",\n          \"citations\": [\n            {\n              \"source_id\": \"13\",\n              \"notes\": \"PDGFRA and EGFR are frequently amplified in high-grade astrocytomas driving proliferation and survival\"\n            },\n            {\n              \"source_id\": \"9\",\n              \"notes\": \"PDGFRA amplification in glioblastoma often occurs with EGFR or MET amplification\"\n            }\n          ],\n          \"genes\": [\"PDGFRA\", \"EGFR\", \"FGF14\", \"NTRK3\"]\n        },\n        {\n          \"name\": \"Downstream signaling cascade activation\",\n          \"citations\": [\n            {\n              \"source_id\": \"34\",\n              \"notes\": \"PKA-mediated phosphorylation of calcium channels downstream of dopamine receptor signaling\"\n            }\n          ],\n          \"genes\": [\"PRKCA\", \"MAP3K1\", \"TNK2\", \"SH3KBP1\", \"SH3D19\"]\n        },\n        {\n          \"name\": \"Integration of multiple signaling inputs\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"PEAK1 mediates crosstalk between integrin signaling and receptor tyrosine kinase pathways\"\n            }\n          ],\n          \"genes\": [\"PEAK1\", \"DENND2A\", \"ARFGEF3\"]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Growth factor receptor complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"13\",\n              \"notes\": \"PDGFRA and EGFR form activated signaling complexes in glioblastoma\"\n            }\n          ],\n          \"genes\": [\"PDGFRA\", \"EGFR\"]\n        },\n        {\n          \"name\": \"Cytoplasmic signaling adaptors\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"Adapter proteins link receptor activation to downstream effectors\"\n            }\n          ],\n          \"genes\": [\"SH3KBP1\", \"SH3D19\", \"TNK2\"]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Enhanced responsiveness to growth factors in tumor microenvironment\",\n        \"Increased proliferation through activation of PI3K/Akt and MAPK pathways\",\n        \"Enhanced survival signaling reducing apoptosis despite stress conditions\",\n        \"Amplified migration response to growth factor gradients\"\n      ],\n      \"evidence_summary\": \"Growth factor receptor signaling represents a critical driver of astrocytoma proliferation and survival. PDGFRA and EGFR alterations are among the most common genetic changes in high-grade astrocytomas, and the presence of multiple effector proteins amplifies the impact of these receptors. The inclusion of FGF14 suggests potential sensitization to FGF signaling, which could be therapeutically exploited through FGF pathway inhibitors. Importantly, the presence of integrin pathway components like PEAK1 alongside growth factor receptors suggests that these pathways are coordinately active and may exhibit crosstalk, potentially enabling cells to respond to both growth factors and mechanical cues from the extracellular matrix.\",\n      \"significance_score\": 0.86,\n      \"citations\": [\n        {\n          \"source_id\": \"13\",\n          \"notes\": \"PDGFRA and EGFR alterations drive high-grade astrocytoma proliferation\"\n        },\n        {\n          \"source_id\": \"9\",\n          \"notes\": \"PDGFRA amplification in glioblastoma often co-occurs with other RTK alterations\"\n        },\n        {\n          \"source_id\": \"25\",\n          \"notes\": \"PEAK1 integration of integrin and RTK signaling\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"PDGFRA\", \"EGFR\", \"FGF14\", \"NTRK3\", \"PRKCA\", \"MAP3K1\", \"TNK2\", \"SH3KBP1\", \"SH3D19\", \"PEAK1\", \"DENND2A\", \"ARFGEF3\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"PI3K\", \"Akt\", \"MAPK/ERK\", \"mTOR\", \"JAK/STAT\", \"SOS\", \"Grb2\"],\n        \"citations\": [\n          {\n            \"source_id\": \"13\",\n            \"notes\": \"Classical downstream effectors of growth factor receptors\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Ion Channel Diversity and Neuronal-Like Electrophysiology\",\n      \"description\": \"Expression of extensive repertoire of voltage-gated ion channels including potassium, sodium, and calcium channels that mediate neuronal-like electrical excitability and calcium signaling in tumor cells normally lacking such properties, enabling calcium-dependent signaling cascades and altered cellular dynamics.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Voltage-gated potassium channel activity\",\n          \"citations\": [\n            {\n              \"source_id\": \"34\",\n              \"notes\": \"L-type calcium channels CaV1.2 modulate neuronal excitability and synaptic plasticity\"\n            }\n          ],\n          \"genes\": [\"KCND2\", \"KCND3\", \"KCNIP1\", \"KCNIP4\", \"KCNMB2\", \"KCNMB2-AS1\", \"KCNQ1OT1\"]\n        },\n        {\n          \"name\": \"Voltage-gated sodium channel activity\",\n          \"citations\": [\n            {\n              \"source_id\": \"34\",\n              \"notes\": \"Sodium channels generate action potential upstroke in excitable cells\"\n            }\n          ],\n          \"genes\": [\"SCN1A\", \"SCN3A\"]\n        },\n        {\n          \"name\": \"Calcium channel-mediated signaling\",\n          \"citations\": [\n            {\n              \"source_id\": \"34\",\n              \"notes\": \"L-type calcium channels CaV1.2 are critical mediators of dopamine signaling affecting spatial working memory\"\n            }\n          ],\n          \"genes\": [\"CACNG4\"]\n        },\n        {\n          \"name\": \"Calcium-activated processes\",\n          \"citations\": [\n            {\n              \"source_id\": \"24\",\n              \"notes\": \"Astrocytes signal using calcium and potassium gradients; calcium signaling links to metabolic coupling and neuroinflammation\"\n            }\n          ],\n          \"genes\": [\"KCNMB2\", \"PDE4B\"]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Kv4 potassium channel complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"34\",\n              \"notes\": \"KCNIP proteins associate with Kv4 channels as accessory subunits\"\n            }\n          ],\n          \"genes\": [\"KCND2\", \"KCND3\", \"KCNIP1\", \"KCNIP4\"]\n        },\n        {\n          \"name\": \"BK potassium channel complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"34\",\n              \"notes\": \"KCNMB2 encodes auxiliary subunit regulating BK channel properties\"\n            }\n          ],\n          \"genes\": [\"KCNMB2\", \"KCNMB2-AS1\"]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Acquisition of neuronal-like electrical properties enabling action potential-like events\",\n        \"Enhanced calcium influx through multiple channel types amplifying calcium-dependent signaling\",\n        \"Coupling between membrane potential and metabolic state through ion gradient maintenance\",\n        \"Potential for activity-dependent changes in gene expression through calcium-CREB signaling\"\n      ],\n      \"evidence_summary\": \"The extensive ion channel repertoire in this astrocytoma gene list represents a striking departure from normal mature astrocyte biology, which is characterized by minimal ion channel diversity. This program is particularly notable because it suggests astrocytomas may engage neuronal-like electrical properties that could fundamentally alter how cells respond to stimuli and communicate with their environment. The presence of both Kv4 and BK channel subunits suggests that calcium-activated potassium signaling may be particularly important. The coordinate expression of sodium and potassium channels suggests potential for action potential-like events, which could enable rapid signal propagation within tumors or enhanced responsiveness to depolarizing signals from adjacent neurons. This program likely reflects either retention of ion channels from a neural progenitor cell stage that normally expresses these genes during development, or acquisition of such genes during malignant transformation.\",\n      \"significance_score\": 0.81,\n      \"citations\": [\n        {\n          \"source_id\": \"34\",\n          \"notes\": \"Ion channels including CaV1.2 and potassium channels mediate neuronal excitability and plasticity\"\n        },\n        {\n          \"source_id\": \"24\",\n          \"notes\": \"Astrocytes utilize calcium and potassium signaling for cellular functions\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"KCND2\", \"KCND3\", \"KCNIP1\", \"KCNIP4\", \"KCNMB2\", \"KCNMB2-AS1\", \"KCNQ1OT1\", \"SCN1A\", \"SCN3A\", \"CACNG4\", \"PDE4B\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"Voltage sensor domains\", \"Pore-forming subunits\", \"Auxiliary subunits\", \"Calcium/calmodulin-dependent kinases\"],\n        \"citations\": [\n          {\n            \"source_id\": \"34\",\n            \"notes\": \"Core ion channel components\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Glutamatergic Synaptic Transmission\",\n      \"description\": \"Expression of ionotropic AMPA and kainate-type glutamate receptors and metabotropic glutamate receptors enabling direct responsiveness to extracellular glutamate, coupled with presynaptic neurotransmitter release machinery and postsynaptic scaffold proteins that support glutamate-dependent signaling and calcium influx.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"AMPA receptor-mediated fast synaptic transmission\",\n          \"citations\": [\n            {\n              \"source_id\": \"5\",\n              \"notes\": \"GRIA2 encodes AMPA receptor subunit 2, mediating fast glutamatergic synaptic transmission\"\n            },\n            {\n              \"source_id\": \"8\",\n              \"notes\": \"NGN2 neurons express multiple AMPA receptor subunits (GRIA1-4) and metabotropic glutamate receptors\"\n            }\n          ],\n          \"genes\": [\"GRIA2\", \"GRIA3\", \"GRID2\", \"CACNG4\"]\n        },\n        {\n          \"name\": \"Metabotropic glutamate receptor signaling\",\n          \"citations\": [\n            {\n              \"source_id\": \"8\",\n              \"notes\": \"Co-cultures express metabotropic glutamate receptors (GRM1-8) enabling G-protein coupled signaling\"\n            },\n            {\n              \"source_id\": \"40\",\n              \"notes\": \"GRM5 and GRM6-8 are metabotropic glutamate receptors activated by extracellular glutamate\"\n            }\n          ],\n          \"genes\": [\"GRM5\"]\n        },\n        {\n          \"name\": \"Glutamate receptor-mediated calcium entry\",\n          \"citations\": [\n            {\n              \"source_id\": \"24\",\n              \"notes\": \"Calcium signaling through receptors drives metabolic coupling and cellular responses\"\n            }\n          ],\n          \"genes\": [\"GRIA2\", \"GRIA3\", \"GRM5\", \"CACNG4\"]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"AMPA receptor complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"5\",\n              \"notes\": \"AMPA receptors assemble as heterotetramers with distinct kinetic properties based on subunit composition\"\n            }\n          ],\n          \"genes\": [\"GRIA2\", \"GRIA3\", \"CACNG4\"]\n        },\n        {\n          \"name\": \"Metabotropic glutamate receptor signaling complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"40\",\n              \"notes\": \"Metabotropic glutamate receptors couple to G-proteins and activate downstream signaling\"\n            }\n          ],\n          \"genes\": [\"GRM5\"]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Direct responsiveness to neuronal glutamate release promoting tumor cell migration and proliferation\",\n        \"Calcium influx through AMPA receptors enabling activation of calcium-dependent transcription factors\",\n        \"G-protein coupled signaling through metabotropic receptors promoting diverse cellular responses\",\n        \"Establishment of glutamate-dependent tumor-neuron crosstalk within the microenvironment\"\n      ],\n      \"evidence_summary\": \"The presence of multiple glutamate receptor subtypes in this astrocytoma gene list is highly significant and suggests that tumor cells have either retained or acquired capacity for direct glutamatergic signaling. In normal physiology, glutamate released by neurons activates receptors on adjacent astrocytes, modulating astrocyte calcium signaling and triggering metabolic coupling. In astrocytoma, enhanced glutamate receptor expression could create aberrant tumor-neuron communication loops where neuronal glutamate release drives tumor cell proliferation and migration. This is particularly relevant given that astrocytomas are highly infiltrative and establish intimate contacts with neurons. Recent work has demonstrated that glutamate signaling promotes glioma cell invasiveness and stemness, suggesting this program represents a critical vulnerability. Interestingly, the presence of ionotropic AMPA receptors (typically neuronal) combined with the general astrocytoma context suggests cells have either failed to complete astrocytic differentiation or that neuronal genes are ectopically expressed.\",\n      \"significance_score\": 0.79,\n      \"citations\": [\n        {\n          \"source_id\": \"5\",\n          \"notes\": \"GRIA2 is AMPA receptor subunit mediating fast glutamatergic transmission\"\n        },\n        {\n          \"source_id\": \"8\",\n          \"notes\": \"Co-culture models express AMPA and metabotropic glutamate receptors\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"GRIA2\", \"GRIA3\", \"GRM5\", \"GRID2\", \"CACNG4\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"GRIA1\", \"GRIA4\", \"GRM1-4\", \"GRM6-8\", \"Post-synaptic density scaffolds\", \"PLC-IP3-Ca2+ release machinery\"],\n        \"citations\": [\n          {\n            \"source_id\": \"8\",\n            \"notes\": \"Additional glutamate receptor subunits and signaling machinery\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Transcriptional Reprogramming and EMT Control\",\n      \"description\": \"Dysregulation of developmental transcription factors that control neural progenitor cell identity and differentiation status, combined with epithelial-mesenchymal transition (EMT) factors that promote migratory and invasive phenotypes, maintaining cells in intermediate developmental states with reduced differentiation.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"EMT transcription factor activity\",\n          \"citations\": [\n            {\n              \"source_id\": \"28\",\n              \"notes\": \"ZEB1 is pivotal EMT transcription factor with C2H2-type zinc fingers recognizing E-box-like promoter elements; forms positive feedback loop with TNS1 stabilizing ZEB1 protein\"\n            }\n          ],\n          \"genes\": [\"ZEB1\", \"ETV5\"]\n        },\n        {\n          \"name\": \"Neural progenitor cell identity maintenance\",\n          \"citations\": [\n            {\n              \"source_id\": \"27\",\n              \"notes\": \"INSM1 governs neuronal progenitor state driving glioblastoma; expressed in intermediate progenitor cells during cortical development\"\n            }\n          ],\n          \"genes\": [\"SOX2-OT\", \"SOX5\", \"MYT1\", \"ETV5\"]\n        },\n        {\n          \"name\": \"Developmental gene expression programming\",\n          \"citations\": [\n            {\n              \"source_id\": \"27\",\n              \"notes\": \"Tumor cell evolution triggers transitions toward neuronal progenitor network\"\n            }\n          ],\n          \"genes\": [\"KLF12\", \"ESRRG\", \"NPAS3\"]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"ZEB1-containing transcriptional repressor complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"28\",\n              \"notes\": \"ZEB1 recruits corepressors to regulate E-cadherin and other genes\"\n            }\n          ],\n          \"genes\": [\"ZEB1\"]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Maintenance of intermediate developmental states with reduced commitment to astrocytic differentiation\",\n        \"Increased expression of genes promoting migration and reduced expression of epithelial genes\",\n        \"Dynamic switching between proliferative and migratory states enabling adaptability to microenvironmental changes\",\n        \"Sustained expression of genes normally silenced during astrocyte maturation\"\n      ],\n      \"evidence_summary\": \"The transcriptional reprogramming program identifies a central feature of astrocytoma pathogenesis—the failure or reversal of normal developmental differentiation. The presence of ZEB1, a canonical EMT transcription factor, combined with developmental progenitor genes like those in the SOX family and INSM1-associated networks suggests that astrocytomas maintain intermediate developmental states characterized by reduced differentiation. Recent work has demonstrated that glioblastomas explicitly maintain neuronal progenitor-like states through INSM1-dependent transcriptional programs, and the presence of SOX genes in this list suggests similar developmental state maintenance. Importantly, this program is distinct from simple dedifferentiation—rather, it represents active engagement of developmental programs that promote both plasticity and migratory capacity. The presence of both ZEB1 and developmental progenitor genes suggests a cell state that is simultaneously migratory and developmentally flexible, maximizing tumor adaptability.\",\n      \"significance_score\": 0.84,\n      \"citations\": [\n        {\n          \"source_id\": \"28\",\n          \"notes\": \"ZEB1 is pivotal EMT transcription factor stabilized by TNS1 forming positive feedback loop\"\n        },\n        {\n          \"source_id\": \"27\",\n          \"notes\": \"INSM1 governs neuronal progenitor state that drives glioblastoma tumorigenicity\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"ZEB1\", \"SOX2-OT\", \"SOX5\", \"MYT1\", \"ETV5\", \"KLF12\", \"ESRRG\", \"NPAS3\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"INSM1\", \"TNS1\", \"E-cadherin\", \"Snail\", \"Slug\", \"Twist\"],\n        \"citations\": [\n          {\n            \"source_id\": \"28\",\n            \"notes\": \"Additional EMT transcription factors and ZEB1 regulatory partners\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Extracellular Matrix Remodeling and Proteolysis\",\n      \"description\": \"Coordinated production of extracellular matrix components combined with expression of matrix-degrading proteases and metalloproteinases, enabling dynamic remodeling of the tumor microenvironment, invasion through tissue barriers, and generation of bioactive matrix fragments that promote further tumor progression.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Matrix metalloproteinase-mediated degradation\",\n          \"citations\": [\n            {\n              \"source_id\": \"32\",\n              \"notes\": \"Matrix metalloproteinases including MMP14 degrade extracellular matrix in physiological and pathological processes\"\n            }\n          ],\n          \"genes\": [\"MMP16\"]\n        },\n        {\n          \"name\": \"Extracellular matrix protein synthesis and modification\",\n          \"citations\": [\n            {\n              \"source_id\": \"13\",\n              \"notes\": \"Extracellular matrix components provide structural support and signaling substrates\"\n            }\n          ],\n          \"genes\": [\"COL4A3\", \"COL4A4\", \"COL20A1\", \"TNR\", \"VCAN\", \"BCAN\", \"CSPG5\", \"CSMD3\"]\n        },\n        {\n          \"name\": \"Proteoglycan-mediated cell-matrix interactions\",\n          \"citations\": [\n            {\n              \"source_id\": \"14\",\n              \"notes\": \"Astrocytes engage in immune microenvironment remodeling affecting tumor progression\"\n            }\n          ],\n          \"genes\": [\"VCAN\", \"BCAN\", \"CSPG5\", \"CSMD3\"]\n        },\n        {\n          \"name\": \"Glycosylation and post-translational matrix modification\",\n          \"citations\": [\n            {\n              \"source_id\": \"13\",\n              \"notes\": \"Matrix glycosylation affects cell-matrix interactions and migration\"\n            }\n          ],\n          \"genes\": [\"CHST9\", \"CHST11\", \"COLGALT2\", \"XYLT1\"]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Type IV collagen-rich basement membranes\",\n          \"citations\": [\n            {\n              \"source_id\": \"13\",\n              \"notes\": \"Type IV collagen (COL4A3, COL4A4) forms structural basement membranes\"\n            }\n          ],\n          \"genes\": [\"COL4A3\", \"COL4A4\"]\n        },\n        {\n          \"name\": \"Brain-specific extracellular matrix components\",\n          \"citations\": [\n            {\n              \"source_id\": \"24\",\n              \"notes\": \"Perineuronal nets contain proteoglycans and other ECM components supporting synaptic stability\"\n            }\n          ],\n          \"genes\": [\"TNR\", \"BCAN\", \"VCAN\"]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Enhanced invasion through basement membranes and stromal matrices via MMP-mediated degradation\",\n        \"Generation of bioactive matrix fragments promoting cell migration and signaling\",\n        \"Remodeling of tumor microenvironment to favor vascularization and immune infiltration\",\n        \"Dynamic matrix production and degradation creating permissive migration corridors\"\n      ],\n      \"evidence_summary\": \"The extracellular matrix remodeling program reflects the known invasive behavior of astrocytomas, which migrate through brain tissue by degrading barriers. The presence of MMP16, a membrane-anchored metalloproteinase, combined with extensive matrix component production suggests a coordinated program of simultaneous matrix degradation and synthesis. This enables astrocytomas to create invasion corridors by degrading existing matrix while simultaneously depositing new matrix tailored to promote migration. The presence of proteoglycans like VCAN and BCAN, enriched in perineuronal nets, suggests the tumor may particularly target these specialized extracellular matrix structures that normally support synaptic organization. The coordinate expression of multiple collagen types suggests wholesale remodeling of the stromal microenvironment.\",\n      \"significance_score\": 0.82,\n      \"citations\": [\n        {\n          \"source_id\": \"32\",\n          \"notes\": \"Matrix metalloproteinases degrade extracellular matrix components\"\n        },\n        {\n          \"source_id\": \"13\",\n          \"notes\": \"Extracellular matrix components and their modifications in tumor biology\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"MMP16\", \"COL4A3\", \"COL4A4\", \"COL20A1\", \"TNR\", \"VCAN\", \"BCAN\", \"CSPG5\", \"CSMD3\", \"CRISPLD2\", \"CHST9\", \"CHST11\", \"COLGALT2\", \"XYLT1\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"MMP2\", \"MMP9\", \"ADAMTS\", \"Tissue inhibitors of MMPs (TIMPs)\", \"Collagenase\"],\n        \"citations\": [\n          {\n            \"source_id\": \"32\",\n            \"notes\": \"Additional matrix-degrading proteinases and their regulators\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Calcium Signaling and Metabolic Coupling\",\n      \"description\": \"Integration of calcium signaling with cellular metabolism through expression of calcium-sensing ion channels, calcium/cAMP-coupled signaling elements, and metabolic transporters that collectively link intracellular calcium dynamics to energy substrate utilization and astrocyte-neuron metabolic support.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Calcium-activated ion channel regulation\",\n          \"citations\": [\n            {\n              \"source_id\": \"24\",\n              \"notes\": \"Astrocytes signal using calcium and potassium gradients; calcium signaling dysregulation links to neuroinflammation\"\n            }\n          ],\n          \"genes\": [\"KCNMB2\", \"KCND2\", \"KCND3\", \"PDE4B\"]\n        },\n        {\n          \"name\": \"Calcium extrusion and homeostasis\",\n          \"citations\": [\n            {\n              \"source_id\": \"24\",\n              \"notes\": \"Sodium-calcium exchangers and associated transporters regulate intracellular calcium\"\n            }\n          ],\n          \"genes\": [\"SLC24A3\"]\n        },\n        {\n          \"name\": \"Calcium-cAMP signaling integration\",\n          \"citations\": [\n            {\n              \"source_id\": \"34\",\n              \"notes\": \"PDE4 phosphodiesterases degrade cAMP, integrating calcium and cAMP signaling\"\n            }\n          ],\n          \"genes\": [\"PDE4B\"]\n        },\n        {\n          \"name\": \"Metabolic substrate transport and coupling\",\n          \"citations\": [\n            {\n              \"source_id\": \"24\",\n              \"notes\": \"Astrocytes engage in metabolic coupling with neurons through lactate shuttle and glucose metabolism\"\n            }\n          ],\n          \"genes\": [\"SLC2A13\", \"SLC4A10\"]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"BK potassium channel-calcium sensor complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"24\",\n              \"notes\": \"BK channels couple calcium influx to membrane hyperpolarization\"\n            }\n          ],\n          \"genes\": [\"KCNMB2\"]\n        },\n        {\n          \"name\": \"Sodium-calcium exchanger\",\n          \"citations\": [\n            {\n              \"source_id\": \"24\",\n              \"notes\": \"Na-Ca exchangers regulate calcium extrusion\"\n            }\n          ],\n          \"genes\": [\"SLC24A3\"]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Coupling between intracellular calcium elevation and changes in membrane potential\",\n        \"Integration of calcium signals with cAMP-dependent responses enabling complex signaling\",\n        \"Dynamic regulation of metabolic substrate availability based on cellular activity state\",\n        \"Potential metabolic competition with adjacent neurons for shared substrates\"\n      ],\n      \"evidence_summary\": \"The calcium-metabolic coupling program reflects emerging understanding that astrocyte function depends critically on proper coordination between calcium signaling and metabolic processes. Recent work has highlighted that dysregulation of astrocytic calcium signaling, particularly through aberrant calcineurin-NFAT activity, disrupts metabolic coupling and contributes to neuroinflammation and neurodegeneration in multiple disease contexts. The presence of genes supporting both calcium regulation and metabolic substrate transport suggests that astrocytomas may maintain coordinated calcium-metabolic signaling, potentially enabling them to compete more effectively with neurons for metabolic resources. The presence of SLC2A13 (monocarboxylate transporter) and SLC4A10 (sodium-dependent bicarbonate transporter) suggests active regulation of lactate and pH-dependent metabolic signaling. This program is particularly relevant in the context of gliomas, which are known to alter tumor microenvironment metabolism and create immunosuppressive conditions through lactate production and acidification.\",\n      \"significance_score\": 0.75,\n      \"citations\": [\n        {\n          \"source_id\": \"24\",\n          \"notes\": \"Astrocyte calcium signaling dysregulation links to neuroinflammation and metabolic coupling disruption\"\n        },\n        {\n          \"source_id\": \"34\",\n          \"notes\": \"Calcium and cAMP signaling integration through phosphodiesterases\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"KCNMB2\", \"KCND2\", \"KCND3\", \"PDE4B\", \"SLC24A3\", \"SLC2A13\", \"SLC4A10\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"IP3R\", \"RyR\", \"STIM1\", \"Orai1\", \"Calmodulin\", \"Calcineurin\", \"NFAT\", \"Glycolytic enzymes\"],\n        \"citations\": [\n          {\n            \"source_id\": \"24\",\n            \"notes\": \"Core calcium and metabolic signaling machinery\"\n          },\n          {\n            \"source_id\": \"37\",\n            \"notes\": \"Orai1 calcium channel functions as signaling hub in astrocytes\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Cell Cycle and Proliferation Control\",\n      \"description\": \"Expression of cell cycle regulators promoting G1/S phase transition combined with apparent reduced expression of cell cycle checkpoints and apoptotic machinery, enabling continuous proliferation with minimal restraint from normal cell cycle surveillance mechanisms.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"G1/S phase progression and cyclin-CDK activity\",\n          \"citations\": [\n            {\n              \"source_id\": \"42\",\n              \"notes\": \"Cyclin E1 forms complex with CDK2 required for G1/S phase transition\"\n            }\n          ],\n          \"genes\": [\"CCND2\"]\n        },\n        {\n          \"name\": \"CDK inhibitor degradation and removal\",\n          \"citations\": [\n            {\n              \"source_id\": \"39\",\n              \"notes\": \"SKP2 is ubiquitin ligase component that degrades CDK inhibitors enabling cell cycle progression\"\n            }\n          ],\n          \"genes\": []\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Cyclin D-CDK4/6 complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"42\",\n              \"notes\": \"Cyclin D2 partners with CDK4/6 for G1/S control\"\n            }\n          ],\n          \"genes\": [\"CCND2\"]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Continuous cell cycle progression with reduced G1/S checkpoint control\",\n        \"Reduced dependency on growth factor signaling for cell cycle progression\",\n        \"Increased proliferation rate enabling rapid tumor growth\",\n        \"Potential genomic instability from bypassed checkpoints\"\n      ],\n      \"evidence_summary\": \"The cell cycle program identified in this gene list is notable primarily for what is absent—genes encoding p53, p16, p21, p27, and other classical CDK inhibitors are not prominently represented. TP53 mutations occur in the vast majority of high-grade astrocytomas and are common in lower-grade lesions, suggesting that loss of p53-mediated checkpoints is a hallmark of these tumors. The presence of CCND2 without corresponding checkpoint genes suggests a bias toward proliferation. However, the relative underrepresentation of this program compared to migration and adhesion programs in the gene list is notable, suggesting that proliferation control may be achieved through upstream mechanisms (growth factor signaling, through PDGFRA and EGFR) rather than through constitutive overexpression of cell cycle machinery.\",\n      \"significance_score\": 0.68,\n      \"citations\": [\n        {\n          \"source_id\": \"42\",\n          \"notes\": \"CCNE1 and cyclin D promote G1/S phase transition\"\n        },\n        {\n          \"source_id\": \"39\",\n          \"notes\": \"SKP2 mediates degradation of CDK inhibitors\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"CCND2\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"TP53\", \"RB\", \"p16\", \"p21\", \"p27\", \"CDK4\", \"CDK6\"],\n        \"citations\": [\n          {\n            \"source_id\": \"12\",\n            \"notes\": \"TP53 mutations in astrocytomas disrupt cell cycle control\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"RNA Processing and Post-Transcriptional Regulation\",\n      \"description\": \"Expression of RNA-binding proteins and splicing regulators that modulate alternative splicing patterns and mRNA stability, enabling dynamic control of protein expression for genes whose transcription may be constitutively elevated, providing additional layer of post-transcriptional regulation.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Alternative splicing regulation\",\n          \"citations\": [\n            {\n              \"source_id\": \"21\",\n              \"notes\": \"NOVA1 is RNA-binding protein regulating alternative splicing of multiple neuronal development genes\"\n            }\n          ],\n          \"genes\": [\"NOVA1\"]\n        },\n        {\n          \"name\": \"mRNA stability and localization control\",\n          \"citations\": [\n            {\n              \"source_id\": \"21\",\n              \"notes\": \"KH-domain RNA-binding proteins regulate mRNA stability and cellular localization\"\n            }\n          ],\n          \"genes\": [\"KHDRBS3\"]\n        },\n        {\n          \"name\": \"Protein stability and ubiquitin-mediated degradation\",\n          \"citations\": [\n            {\n              \"source_id\": \"28\",\n              \"notes\": \"USP54-like deubiquitinating enzymes regulate protein stability of transcription factors\"\n            }\n          ],\n          \"genes\": [\"USP54\"]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"RNA-protein complexes\",\n          \"citations\": [\n            {\n              \"source_id\": \"21\",\n              \"notes\": \"NOVA1 and KHDRBS3 form ribonucleoprotein complexes regulating target RNAs\"\n            }\n          ],\n          \"genes\": [\"NOVA1\", \"KHDRBS3\"]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Fine-tuning of protein expression through alternative splicing of genes with elevated transcription\",\n        \"Selective stabilization or destabilization of specific mRNAs enabling dynamic response to signals\",\n        \"Post-translational protein stability regulation complementing transcriptional control\",\n        \"Potential generation of protein isoforms with altered biological activities\"\n      ],\n      \"evidence_summary\": \"The RNA processing program represents a secondary layer of gene expression control that enables more nuanced regulation of cellular phenotypes. NOVA1, while best characterized in the context of neuronal development where it regulates splicing of genes controlling synaptic transmission, has increasingly been recognized as dysregulated in various cancers. Its presence in this astrocytoma gene list suggests potential aberrant regulation of splicing patterns in developmental genes, potentially maintaining cells in intermediate developmental states. The presence of KHDRBS3 and USP54 suggests coordinate control of mRNA and protein stability, enabling cells to maintain high mRNA levels while actually producing controlled amounts of protein through post-translational mechanisms.\",\n      \"significance_score\": 0.70,\n      \"citations\": [\n        {\n          \"source_id\": \"21\",\n          \"notes\": \"NOVA1 regulates alternative splicing of developmental genes in neural progenitors\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"NOVA1\", \"KHDRBS3\", \"USP54\", \"DISC1\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"hnRNPs\", \"SR proteins\", \"snRNPs\", \"Proteolytic enzymes\"],\n        \"citations\": [\n          {\n            \"source_id\": \"21\",\n            \"notes\": \"Classical splicing machinery components\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Vesicular Trafficking and Exosome Biogenesis\",\n      \"description\": \"Expression of ESCRT machinery components, SNARE proteins, and vesicular trafficking regulators supporting formation and release of extracellular vesicles (exosomes), enabling intercellular communication through transfer of proteins, lipids, and RNAs that promote tumor progression and immune evasion.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Multivesicular body biogenesis and ESCRT function\",\n          \"citations\": [\n            {\n              \"source_id\": \"44\",\n              \"notes\": \"TSG101 is component of ESCRT machinery required for endosomal sorting and multivesicular body formation\"\n            }\n          ],\n          \"genes\": [\"TSG101\"]\n        },\n        {\n          \"name\": \"Vesicle-associated membrane protein function\",\n          \"citations\": [\n            {\n              \"source_id\": \"41\",\n              \"notes\": \"VAMP7 participates in SNARE-mediated fusion of endosomal and recycling vesicles\"\n            }\n          ],\n          \"genes\": [\"VAMP7\"]\n        },\n        {\n          \"name\": \"Vesicular trafficking and membrane reorganization\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"Lipid-binding proteins and trafficking regulators coordinate membrane organization\"\n            }\n          ],\n          \"genes\": [\"GRAMD1B\", \"PLPP4\"]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"ESCRT complex machinery\",\n          \"citations\": [\n            {\n              \"source_id\": \"44\",\n              \"notes\": \"ESCRT machinery including TSG101 sorts cargo into multivesicular bodies\"\n            }\n          ],\n          \"genes\": [\"TSG101\"]\n        },\n        {\n          \"name\": \"SNARE complexes\",\n          \"citations\": [\n            {\n              \"source_id\": \"41\",\n              \"notes\": \"VAMP7-containing SNARE complexes mediate membrane fusion\"\n            }\n          ],\n          \"genes\": [\"VAMP7\"]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Enhanced exosome production and release enabling intercellular transfer of tumor-promoting signals\",\n        \"Increased transfer of proteins and miRNAs to neighboring cells promoting tumor progression\",\n        \"Potential immune evasion through exosome-mediated transfer of immunosuppressive molecules\",\n        \"Horizontal transfer of oncogenic signals amplifying tumor heterogeneity\"\n      ],\n      \"evidence_summary\": \"Recent work has identified exosome-mediated intercellular communication as a critical mechanism in tumor progression, with glioma-derived exosomes promoting both intra-tumoral progression and colonization of distant brain regions. The presence of ESCRT machinery components including TSG101 combined with SNARE proteins like VAMP7 suggests that astrocytomas engaging this program may be particularly adept at exosome biogenesis and release. The presence of GRAMD1B and lipid-binding proteins suggests additional sophistication in vesicular organization and membrane remodeling. Recent studies have demonstrated that glioma-derived exosomes can transfer bioactive molecules including growth factors, signaling proteins, and miRNAs that promote both tumor progression and immunosuppression in the microenvironment.\",\n      \"significance_score\": 0.76,\n      \"citations\": [\n        {\n          \"source_id\": \"44\",\n          \"notes\": \"TSG101 is ESCRT component required for exosome biogenesis\"\n        },\n        {\n          \"source_id\": \"41\",\n          \"notes\": \"VAMP7 mediates endosomal trafficking essential for MT1-MMP recycling during invasion\"\n        },\n        {\n          \"source_id\": \"25\",\n          \"notes\": \"Extracellular vesicles modulate integrin signaling and enhance stemness\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"TSG101\", \"VAMP7\", \"GRAMD1B\", \"PLPP4\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"ALIX/PDCD6IP\", \"Vps4\", \"Rab proteins\", \"SNAREs (SNARE)\", \"Synaptobrevins\"],\n        \"citations\": [\n          {\n            \"source_id\": \"44\",\n            \"notes\": \"Additional ESCRT and trafficking machinery components\"\n          }\n        ]\n      }\n    }\n  ],\n  \"method\": {\n    \"clustering_basis\": [\n      \"Functional annotation from literature\",\n      \"Gene ontology analysis\",\n      \"Co-expression patterns in developmental and disease contexts\",\n      \"Known protein-protein interactions\",\n      \"Pathway database information\"\n    ],\n    \"notes\": \"Analysis prioritized genes with clear functional roles in astrocyte biology and astrocytoma pathogenesis, identifying twelve major programs reflecting normal neural development, aberrant differentiation, and pro-tumoral phenotypes. Programs were validated against recent literature on glioma pathogenesis, particularly studies on developmental plasticity and tumor progression mechanisms.\"\n  },\n  \"version\": \"1.0\"\n}\n```\n\n---\n\nThis comprehensive analysis reveals that the astrocytoma-associated gene list reflects not simply a collection of randomly dysregulated genes, but rather coherent functional programs reflecting interrupted developmental differentiation combined with activation of pro-invasive, pro-proliferative, and pro-migratory machinery. The coordinate upregulation of adhesion molecules, migration regulators, and developmental transcription factors alongside ion channels and glutamate receptors more typically expressed in neurons suggests that these astrocytomas originate from or maintain characteristics of neural progenitor cells that have failed to complete appropriate differentiation. The identification of these programs provides a framework for understanding astrocytoma pathogenesis and suggests that effective therapeutic strategies will require simultaneous targeting of multiple coordinately active programs rather than individual gene products.",
    "citations": [
      "https://www.ncbi.nlm.nih.gov/gene/6422",
      "https://www.science.org/doi/10.1126/sciadv.adp3059",
      "https://www.ncbi.nlm.nih.gov/gene/2735",
      "https://www.nature.com/articles/s41467-025-67591-x_reference.pdf",
      "https://www.ncbi.nlm.nih.gov/gene/2891",
      "https://www.nature.com/articles/s41467-025-66109-9_reference.pdf",
      "https://www.nature.com/articles/s42003-025-09138-w",
      "https://www.nature.com/articles/s41380-025-03384-4",
      "https://www.ncbi.nlm.nih.gov/gene/5156",
      "https://www.ncbi.nlm.nih.gov/gene/19211",
      "https://www.ncbi.nlm.nih.gov/gene/26047",
      "https://www.ncbi.nlm.nih.gov/clinvar/variation/VCV000012374",
      "https://www.nature.com/articles/s41698-025-01151-w",
      "https://pubmed.ncbi.nlm.nih.gov/41327009/",
      "https://pubmed.ncbi.nlm.nih.gov/41377462/?fc=None&ff=20251212152250&v=2.18.0.post22+67771e2",
      "https://www.ncbi.nlm.nih.gov/gene/7422",
      "https://www.nature.com/articles/s41598-025-30291-z_reference.pdf",
      "https://www.ncbi.nlm.nih.gov/gene/22339",
      "https://www.ncbi.nlm.nih.gov/gene/10763",
      "https://www.ncbi.nlm.nih.gov/gene/10215",
      "https://www.nature.com/articles/s41380-025-03364-8",
      "https://www.ncbi.nlm.nih.gov/gene/4133",
      "https://www.nature.com/articles/s41467-025-67354-8",
      "https://www.nature.com/articles/s44324-025-00090-1",
      "https://www.nature.com/articles/s42003-025-09004-9",
      "https://www.nature.com/articles/s41467-025-66371-x",
      "https://www.nature.com/articles/s42003-025-09079-4",
      "https://www.ncbi.nlm.nih.gov/gene/4312",
      "https://www.ncbi.nlm.nih.gov/gene/4763",
      "https://www.ncbi.nlm.nih.gov/gene/6935",
      "https://www.ncbi.nlm.nih.gov/gene/4323",
      "https://www.science.org/doi/10.1126/sciadv.ady7682",
      "https://www.science.org/doi/10.1126/scisignal.adp7760",
      "https://www.ncbi.nlm.nih.gov/gene/5578",
      "https://www.ncbi.nlm.nih.gov/gene/406935",
      "https://www.nature.com/subjects/calcium-signalling/ncomms",
      "https://www.ncbi.nlm.nih.gov/gene/18750",
      "https://www.ncbi.nlm.nih.gov/gene/6502",
      "https://www.ncbi.nlm.nih.gov/gene/2916",
      "https://www.ncbi.nlm.nih.gov/gene/6845",
      "https://www.ncbi.nlm.nih.gov/gene/898",
      "https://www.ncbi.nlm.nih.gov/gene/2918",
      "https://www.ncbi.nlm.nih.gov/gene/7251",
      "http://json-schema.org/draft-07/schema#\","
    ],
    "duration_seconds": 268.5853214263916
  }
}